Would Washington’s FDA fix cure the patients or the drug industry? -

October 20, 2015. ProPublica. In Congress, however, things are looking better for the manufacturers. Legislation is advancing that would speed up the FDA’s approval process for medications and medical devices, offering a rare example of how major initiatives can get traction even in today’s gridlocked Washington.

Agent Orange and Multiple Myeloma? -

Nicholas J. Jury, PhD and Diana Zuckerman, PhD   It has taken many years to determine how Agent Orange exposure during the Vietnam War has harmed the health of those who were exposed. One of the reasons is that it can take decades for cancer to develop after a dangerous exposure.  Agent Orange was used […]